Will AVITA Medical's (RCEL) CEO Transition Reshape Its Long-Term Strategic Direction? [Yahoo! Finance]
Avita Medical, Inc. (RCEL)
Company Research
Source: Yahoo! Finance
the release of preliminary third-quarter revenue guidance of approximately US$17 million and changes to Board leadership roles. This combination of leadership transition and updated revenue outlook signals a period of potential transformation and operational reassessment at AVITA Medical. We'll explore how Cary Vance's appointment as Interim CEO could influence AVITA Medical's outlook and key risks in the investment narrative. The end of cancer? These 28 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's. AVITA Medical Investment Narrative Recap To be a shareholder in AVITA Medical, you need conviction in the company's ability to drive adoption of its RECELL system and diversify its revenue base with new products, while navigating operational and reimbursement complexities. The recent appointment of Cary Vance as Interim CEO signals operational reassessment, but does not materially change the core
Show less
Read more
Impact Snapshot
Event Time:
RCEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RCEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RCEL alerts
High impacting Avita Medical, Inc. news events
Weekly update
A roundup of the hottest topics
RCEL
News
- AVITA Medical to Present at the Piper Sandler 37?? Annual Healthcare ConferenceGlobeNewswire
- Avita Medical (NASDAQ:RCEL) was upgraded by analysts at BTIG Research from a "sell" rating to a "neutral" rating.MarketBeat
- AVITA Medical to Host Investor Webinar Briefing [Yahoo! Finance]Yahoo! Finance
- AVITA Medical to Host Investor Webinar BriefingGlobeNewswire
- Avita Medical (NASDAQ:RCEL) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.MarketBeat
RCEL
Earnings
- 11/6/25 - Miss
RCEL
Sec Filings
- 11/6/25 - Form 10-Q
- 11/6/25 - Form 8-K
- 10/17/25 - Form SCHEDULE
- RCEL's page on the SEC website